Due to changing regulations, Translational Software has been forced to cease offering pharmacogenomic testing solutions in the U.S. market for both new and existing clients. Existing clients should refer to updates on the homepage of the PGxPortal for the latest information regarding the discontinuation of services.
It has been a privilege to work with you in advancing the state of precision medicine over the past decade. We are very sorry that we cannot continue. Thank you very much for your business.
